Like other estrogen-dependent cancers, human seminoma express different estrogens receptors (here ERβ and GPER) and can be activated in different ways both by estrogens and xeno-estrogens depending on their respective affinity and cell microenvironment (receptor expression level, cofactors). The gene discussed is ESR2; the disease is seminoma.